Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zogenix Inc announces sale of SUMAVEL DosePro Migraine Therapy to Endo International

Thursday, 24 Apr 2014 07:30am EDT 

Zogenix Inc:Definitive agreement to sell its SUMAVEL DosePro Needle-free Delivery System migraine therapy business to Endo International plc.Sale for $85 mln in cash and milestone payments of up to $20 mln. 

Related Company News

Company Quote

22 May 2015